A University of Saskatchewan (USask) research team’s discovery of the additional health benefits of an appetite-suppressing protein has doubled the potential for scientists to find new avenues for treating obesity and metabolic disorders in animals and people.
Tempus AI expands oncology collaboration with Takeda
The collaboration aims to utilise Tempus’ real-world data and biological modelling to enhance the development of Takeda’s oncology treatment portfolio. Credit: Lightspring/ Shutterstock. Tempus AI